Dr Simona Grozinsky-Glasberg speaks about her work with neuroendocrine tumours and explains why she believes that investigating mTOR will be an important step towards developing a successful treatment. Dr Grozinsky-Glasberg discusses the current standard treatment for these tumours, outlines the different factors that must be taken into account when deciding which drugs should be used and speaks about exciting new drugs in development.